首页> 外文期刊>Journal of Drug Delivery and Therapeutics >Novel verdicts of nifedipine encapsulated with cyclodextrin in new-fangled form of microsponges
【24h】

Novel verdicts of nifedipine encapsulated with cyclodextrin in new-fangled form of microsponges

机译:新型微囊形式的环糊精包裹硝苯地平的新结论

获取原文
           

摘要

The fundamental approach for the microsponge technologies arises in solid dosage forms because they showing a promising technology for nifedipine drug in hypertension control. As nifedipine drug is chosen due to its hydrophobic nature second short half-life, third low remark in plasma concentration. Cyclodextrin-based microsponges with different polymer are novel finding in the microsphere technology, the crosslinking of polymers blends with respect to cyclodextrin will enhance the entrapment of nifedipine drug in the new-fangled form by emulsification solvent method and futher Lyophilization. The different microsponges batches are formulated the optimize batch was MN3 with angle of repose; 21.80 ± 0.63., Hausner ratio 1.132, Carrs index 0.132 and higher % drug content (80.5 ± 0.97 %). showed 99.41 ± 1.05 % drug release during 36 hr in vitro release . After that the stability data disclose superior drug retention of loaded nifedipine, besides consistent in vitro release pattern over a period of 90 days.
机译:微海绵技术的基本方法以固体剂型出现,因为它们显示了用于硝苯地平药物控制高血压的有前途的技术。选择硝苯地平药物是由于其疏水性,其第二半衰期短,血浆浓度第三低。具有不同聚合物的基于环糊精的微海绵是微球技术中的新发现,通过乳化溶剂法和进一步的冻干,聚合物混合物相对于环糊精的交联将以新的形式增强硝苯地平药物的包封。配制不同的微海绵批次,最优化批次为具有休止角的MN3。 21.80±0.63。,豪斯纳比1.132,卡尔指数0.132和更高的药物含量百分比(80.5±0.97%)。在体外释放36小时内药物释放率为99.41±1.05%。之后,稳定性数据显示了负载的硝苯地平具有优异的药物保留能力,除了在90天内持续的体外释放模式外。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号